Literature DB >> 15301600

Nucleus accumbens acetylcholine regulates appetitive learning and motivation for food via activation of muscarinic receptors.

Wayne E Pratt1, Ann E Kelley.   

Abstract

These experiments tested whether nucleus accumbens muscarinic or nicotinic acetylcholine receptor activation is required for rats to learn to lever press for sucrose. Muscarinic blockade with scopolamine (1.0 microg/side or 10.0 microg/side), but not nicotinic antagonism with mecamylamine (10.0 microg/side), inhibited learning and performance when applied to the core or shell. Further experiments showed that acute accumbens scopolamine treatment increased locomotor activity and reduced sucrose consumption. However, microanalyses of behavioral events in the instrumental chamber revealed that reductions of lever press performance during muscarinic blockade were not due to gross motor dysfunction. Accumbens core scopolamine was subsequently shown to reduce the amount of work rats would expend under a progressive ratio paradigm. These novel results implicate nucleus accumbens muscarinic receptors in the modulation of appetitive learning, performance, and motivation for food.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15301600     DOI: 10.1037/0735-7044.118.4.730

Source DB:  PubMed          Journal:  Behav Neurosci        ISSN: 0735-7044            Impact factor:   1.912


  37 in total

1.  Do psychoactive drugs have a therapeutic role in compulsivity? Studies on schedule-induced polydipsia.

Authors:  Elena Martín-González; Ángeles Prados-Pardo; Santiago Mora; Pilar Flores; Margarita Moreno
Journal:  Psychopharmacology (Berl)       Date:  2018-01-08       Impact factor: 4.530

2.  Muscarinic acetylcholine receptors in the nucleus accumbens core and shell contribute to cocaine priming-induced reinstatement of drug seeking.

Authors:  Judy Yee; Katie R Famous; Thomas J Hopkins; Michael C McMullen; R Christopher Pierce; Heath D Schmidt
Journal:  Eur J Pharmacol       Date:  2010-10-27       Impact factor: 4.432

3.  Blockade of muscarinic acetylcholine receptors in the ventral tegmental area disrupts food-related learning in rats.

Authors:  Ruth Sharf; Robert Ranaldi
Journal:  Psychopharmacology (Berl)       Date:  2005-11-24       Impact factor: 4.530

4.  Blockade of muscarinic acetylcholine receptors in the ventral tegmental area prevents acquisition of food-rewarded operant responding in rats.

Authors:  Ruth Sharf; Jennifer McKelvey; Robert Ranaldi
Journal:  Psychopharmacology (Berl)       Date:  2006-03-09       Impact factor: 4.530

5.  Differential involvement of M1-type and M4-type muscarinic cholinergic receptors in the dorsomedial striatum in task switching.

Authors:  Martha F McCool; Sima Patel; Ravi Talati; Michael E Ragozzino
Journal:  Neurobiol Learn Mem       Date:  2007-08-20       Impact factor: 2.877

6.  Serotonin 1A, 1B, and 7 receptors of the rat medial nucleus accumbens differentially regulate feeding, water intake, and locomotor activity.

Authors:  Kara A Clissold; Eugene Choi; Wayne E Pratt
Journal:  Pharmacol Biochem Behav       Date:  2013-10-11       Impact factor: 3.533

Review 7.  Cholinergic interneurons in the dorsal and ventral striatum: anatomical and functional considerations in normal and diseased conditions.

Authors:  Kalynda K Gonzales; Yoland Smith
Journal:  Ann N Y Acad Sci       Date:  2015-04-15       Impact factor: 5.691

8.  Mechanisms of psychostimulant-induced structural plasticity.

Authors:  Sam A Golden; Scott J Russo
Journal:  Cold Spring Harb Perspect Med       Date:  2012-10-01       Impact factor: 6.915

9.  Nucleus Accumbens Acetylcholine Receptors Modulate Dopamine and Motivation.

Authors:  Anne L Collins; Tara J Aitken; Venuz Y Greenfield; Sean B Ostlund; Kate M Wassum
Journal:  Neuropsychopharmacology       Date:  2016-05-31       Impact factor: 7.853

10.  Muscarinic receptor antagonism causes a functional alteration in nucleus accumbens mu-opiate-mediated feeding behavior.

Authors:  Michelle L Perry; Brian A Baldo; Matthew E Andrzejewski; Ann E Kelley
Journal:  Behav Brain Res       Date:  2008-08-12       Impact factor: 3.332

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.